-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Preventing and Monitoring For Tumor Lysis Syndrome and Other Toxicities of Venetoclax

Program: Education Program
Session: Managing Toxicities of Targeted Therapies in CLL
Saturday, December 5, 2020, 1:55 PM-2:00 PM

Kirsten Fischer, MD

University Hospital Cologne, Cologne, Germany

Disclosures: Fischer: F. Hoffmann-La Roche: Honoraria, Other: travel grants; AbbVie: Honoraria.

Previous Presentation | Next Presentation >>